NYC, New York—A study published in the journal of Biochemistry and Biophysics Reports suggests that tocotrienols may improve brain function in Alzheimer’s Disease (AD). The study suggests that the vitamin E compounds—alpha-tocotrienol (α-T3), gamma-tocotrienol (γ-T3), and alpha-tocopherol—may reduce amyloid beta (Aβ) plaque accumulation and improved cognitive health.
Patients with AD have lower tocopherols and tocotrienol levels compared to the healthy population, furthering the link between vitamin E and cognitive health, noted Bryan See, Vice President of PhytoGaia, in a press release outlining the findings.
